We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Zhejiang Saimo Pharmaceutical Co., Ltd. is an open, cooperative and inclusive platform enterprise providing high-quality and efficient CDMO/CMO services. The company is located in Jinxi Health Biological Industrial Park, Jinhua Development Zone, with a total investment of about 2.05 billion yuan. The GMP standard factory building and supporting laboratory have been built with 140,000 square meters, covering 19 dosage forms such as oral solid, oral liquid, large and small volume injection, eye drops, inhalation solution (including hormones), external ointment cream, and raw material medicine. By the end of October 2023, the company has cooperated with more than 100 pharmaceutical enterprises in China, has declared more than 100 registered varieties of drugs, obtained 3 approved apis to A variety, 8 preparations, and a total of 12 production lines have passed GMP compliance inspection, which can meet the customized production of apis, innovative drugs and generic drugs.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![1-(2-bromophenyl)dibenzo[b,d]furan](https://eimg.pharmasources.com/image/product/20240717/40f1134cded7523d0965e9a6673b8df8jpg!145)
